Literature DB >> 27069130

Vimentin Regulates Invasiveness and Is a Poor Prognostic Marker in Non-small Cell Lung Cancer.

Akira Tadokoro1, Nobuhiro Kanaji2, Dage Liu3, Hiroyasu Yokomise3, Reiji Haba4, Tomoya Ishii2, Takehiro Takagi2, Naoki Watanabe2, Nobuyuki Kita2, Norimitsu Kadowaki2, Shuji Bandoh2.   

Abstract

BACKGROUND: Lung cancer cells often express vimentin. However, the function of vimentin in lung cancer cells has not been fully evaluated.
MATERIALS AND METHODS: We evaluated the association between vimentin expression in resected non-small cell lung cancer (NSCLC) specimens and prognosis. Short-interfering RNA targeting vimentin and establishment of an invasive cell line by repeated selection of invasive cells using a Matrigel membrane invasion chamber system (MICS) were performed. MICS was used to reveal the relationship between invasiveness and vimentin.
RESULTS: Vimentin positivity was significantly associated with a poor prognosis and was significantly lower in squamous cell carcinoma than in adenocarcinoma. In in vitro experiments, silencing of vimentin reduced invasiveness. Highly invasive cell lines exhibited higher expression of vimentin than did parental cells, and invasive ability was reduced by knockdown of vimentin.
CONCLUSION: Vimentin expression is associated with prognosis via alteration of the invasive ability of NSCLC cells. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Lung cancer; invasion; prognosis; vimentin

Mesh:

Substances:

Year:  2016        PMID: 27069130

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  22 in total

1.  Quantitative proteomic analysis of the miR-148a-associated mechanisms of metastasis in non-small cell lung cancer.

Authors:  Dandan Chu; Jing Li; Hechun Lin; Xiao Zhang; Hongyu Pan; Lei Liu; Tao Yu; Mingxia Yan; Ming Yao
Journal:  Oncol Lett       Date:  2018-04-26       Impact factor: 2.967

Review 2.  Targeting the cytoskeleton against metastatic dissemination.

Authors:  Carmen Ruggiero; Enzo Lalli
Journal:  Cancer Metastasis Rev       Date:  2021-01-20       Impact factor: 9.264

3.  Investigation of the Subcellular Localization-Dependent Anti- or Pro-Tumor Functions of Maspin in Human Lung Adenocarcinoma Cell Line.

Authors:  Takahiro Matsushige; Tomohiko Sakabe; Yoshihisa Umekita
Journal:  Yonago Acta Med       Date:  2022-01-04       Impact factor: 1.641

Review 4.  Essential role of aerobic glycolysis in epithelial-to-mesenchymal transition during carcinogenesis.

Authors:  Chandra Prakash Prasad; Ajay Gogia; Atul Batra
Journal:  Clin Transl Oncol       Date:  2022-06-25       Impact factor: 3.340

5.  Mechanism of transmembrane and coiled-coil domain 1 in the regulation of proliferation and migration of A549 cells.

Authors:  Chen Yang; Yuan Wang; Jian-Qi Bai; Jing-Ru Zhang; Pei-Yan Hu; Yan Zhu; Qin Ouyang; Hong-Mei Su; Qiu-Yue Li; Ping Zhang
Journal:  Oncol Lett       Date:  2020-08-26       Impact factor: 2.967

Review 6.  Biology and clinical significance of circulating tumor cell subpopulations in lung cancer.

Authors:  Linda O'Flaherty; Harriet Wikman; Klaus Pantel
Journal:  Transl Lung Cancer Res       Date:  2017-08

7.  Vimentin immunoexpression is associated with higher tumor grade, metastasis, and shorter survival in colorectal cancer.

Authors:  Jaudah Al-Maghrabi
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

8.  STIM1 silencing inhibits the migration and invasion of A549 cells.

Authors:  Yadong Wang; Haiyu Wang; Teng Pan; Li Li; Jiangmin Li; Haiyan Yang
Journal:  Mol Med Rep       Date:  2017-07-15       Impact factor: 2.952

9.  Resistance to epithelial growth factor receptor tyrosine kinase inhibitors in a patient with transformation from lung adenocarcinoma to small cell lung cancer: A case report.

Authors:  Liying Fang; Jian He; Jingwen Xia; Liang Dong; Xiujuan Zhang; Yaqin Chai; Ying Li; Mengjie Niu; Tianxing Hang; Shengqing Li
Journal:  Oncol Lett       Date:  2017-05-23       Impact factor: 2.967

10.  Rac3 Regulates Cell Invasion, Migration and EMT in Lung Adenocarcinoma through p38 MAPK Pathway.

Authors:  Chenlei Zhang; Tieqin Liu; Gebang Wang; Huan Wang; Xiaofang Che; Xinghua Gao; Hongxu Liu
Journal:  J Cancer       Date:  2017-08-02       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.